Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for RLAY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 218.53M
March 31, 2026 189.21M
December 31, 2025 173.87M
September 30, 2025 172.63M
June 30, 2025 171.69M
March 31, 2025 170.48M
December 31, 2024 167.76M
September 30, 2024 166.89M
June 30, 2024 133.32M
March 31, 2024 132.30M
December 31, 2023 127.46M
September 30, 2023 123.16M
June 30, 2023 121.94M
March 31, 2023 121.48M
December 31, 2022 121.11M
Date Value
September 30, 2022 120.81M
June 30, 2022 108.81M
March 31, 2022 108.43M
December 31, 2021 108.21M
September 30, 2021 92.80M
June 30, 2021 92.55M
March 31, 2021 90.43M
December 31, 2020 89.91M
September 30, 2020 89.80M
June 30, 2020 89.97M
March 31, 2020 89.88M
December 31, 2019 89.88M
September 30, 2019 89.88M
June 30, 2019 89.97M
March 31, 2019 89.88M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
AbbVie, Inc. 1.767B
TG Therapeutics, Inc. 153.08M
Karyopharm Therapeutics, Inc. 22.68M
Krystal Biotech, Inc. 29.60M
Akebia Therapeutics, Inc. 271.74M